Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Neoplasms 3 Breast Neoplasms 3 Esophageal Neoplasms 2 the Rate of Participation in Screening for PBC 1 Venous Thromboembolism 1 Uterine Cervical Diseases 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postural Orthostatic Tachycardia Syndrome 1 Postoperative Complications 1 Pneumonia 1 Papillomavirus Infections 1 Pancreatic carcinoma, familial 1 Pancreatic cancer, adult 1 Pancreatic Neoplasms 1 Oncology Problem 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mastocytosis 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Homosexuality 1 Heart Diseases 1 Head and Neck Neoplasms 1 HIV Infections 1

Interventions

ziprasidone 1 enzalutamide 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Surgical Procedures, Operative 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Registries 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Neuropsychological Tests 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Medical Marijuana 1 Mass Screening 1 Magnetoencephalography 1 Lurasidone Hydrochloride 1 Labetalol 1 Histocompatibility Testing 1 Haloperidol 1 Fosfomycin 1 Clozapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Epilepsy × Mass Screening × Clear all

NCT00152659 2023-04-26

Developing Criteria for Cortical Resections

University of Chicago

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡